Feasibility of Multi-gene Panel Testing at the Time of Diagnosis for Patients With Ovarian Cancer

NYU Langone Health

Status: Completed

Conditions: Ovarian Cancer

Study type: Observational

Funder types: Other

Identifiers

NCT03656809

14-01459

Details and patient eligibility

About

The purpose of this study is to determine the feasibility of routine referral to genetic counseling for all patients with a new diagnosis of epithelial ovarian, primary peritoneal or fallopian tube cancer.

Enrollment: 125 patients

Sex: Female

Ages: 18 to 90 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• All subjects must have a new diagnosis of epithelial ovarian, primary peritoneal, fallopian tube or extra- uterine mullerian cancer.
• All subjects must have either undergone primary surgery or be planning neoadjuvant chemotherapy for the treatment of ovarian, primary peritoneal or fallopian tube cancer.
• All subjects must be able to comprehend and communicate in English.
• All subjects must agree to participate.
• A previous diagnosis of cancer is not an exclusion criterion.
• Previous genetic screening is not an exclusion criterion.

Exclusion criteria

• Patients who do not meet the above inclusion criteria.
• Patients with a diagnosis of a low malignant potential mullerian tumor.
• Patients who are not proficient in English language because the survey aspect of this study is comprised of 4 validated surveys that are only available in English language.